Inflammatory bowel disease in primary sclerosing cholangitis: A robust yet changing relationship

Inflammatory Bowel Diseases

Volumn 19, Issue 5, 2013, Pages 1004-1009

  Sinakos, Emmanouil ^a,b   Samuel, Sunil ^a,c   Enders, Felicity ^a   Loftus, Edward V ^a   Sandborn, William J ^d   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

^b ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Endoscopic presentation; Inflammatory bowel disease; Natural history; Primary sclerosing cholangitis; Symptoms; Ulcerative colitis

Indexed keywords

ALKALINE PHOSPHATASE; AZATHIOPRINE; MERCAPTOPURINE; MESALAZINE; URSODEOXYCHOLIC ACID;

ABDOMINAL PAIN; ADULT; ARTICLE; BLEEDING; CLINICAL FEATURE; COHORT ANALYSIS; COLON RESECTION; COLORECTAL TUMOR; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPLASIA; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPY; ENTERITIS; FEMALE; FEVER; HUMAN; ILEITIS; ILEORECTAL ANASTOMOSIS; ILEOSTOMY; MAJOR CLINICAL STUDY; MALE; PANCOLITIS; PHENOTYPE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

EID: 84876370328     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e3182802893     Document Type: Article

References (21)

1. Chapman RW, Arborgh BA, Rhodes JM, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut. 1980;21:870-877.
2. LaRusso NF, Wiesner RH, Ludwig J, et al. Current concepts. Primary sclerosing cholangitis. N Engl J Med. 1984;310:899-903.
3. Silveira MG, Lindor KD. Primary sclerosing cholangitis. Can J Gastroenterol. 2008;22:689-698.
4. Silveira MG, Lindor KD. Clinical features and management of primary sclerosing cholangitis. World J Gastroenterol. 2008;14:3338-3349.
5. Smith MP, Loe RH. Sclerosing cholangitis; review of recent case reports and associated diseases and four new cases. Am J Surg. 1965; 110:239-246.
6. Broome U, Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis. 2006;26:31-41.
7. Loftus EV Jr, Harewood GC, Loftus CG, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54:91-96.
8. Sokol H, Cosnes J, Chazouilleres O, et al. Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. World J Gastroenterol. 2008;14:3497-3503.
9. Faubion WA Jr, Loftus EV, Sandborn WJ, et al. Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with psc. J Pediatr Gastroenterol Nutr. 2001;33:296-300.
10. Soetikno RM, Lin OS, Heidenreich PA, et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc. 2002;56:48-54.
11. Broome U, Lofberg R, Veress B, et al. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology. 1995;22:1404-1408.
12. Penna C, Dozois R, Tremaine W, et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut. 1996;38:234-239.
13. Bergquist A, Said K, Broome U. Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden. Scand J Gastroenterol. 2007;42:88-93.
14. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6; discussion 16-19.
15. Van Assche G, Dignass A, Reinisch W, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: special situations. J Crohns Colitis. 2010;4:63-101.
16. Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660-678.
17. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931-968.
18. Roger D, Vaillant L, Fignon A, et al. Specific pruritic diseases of pregnancy. A prospective study of 3192 pregnant women. Arch Dermatol. 1994;130:734-739.
19. Berstad AE, Aabakken L, Smith HJ, et al. Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis. Clin Gastroenterol Hepatol. 2006;4:514-520.
20. Textor HJ, Flacke S, Pauleit D, et al. Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography. Endoscopy. 2002;34:984-990.
21. Navaneethan U, Venkatesh PG, Lashner BA, et al. Temporal trends in colon neoplasms in patients with primary sclerosing cholangitis and ulcerative colitis. J Crohns Colitis. 2012;6:845-851.